echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Pfizer's encephalitis vaccine has a protective effect of 96-99% and is eligible for priority review by the FDA

    Pfizer's encephalitis vaccine has a protective effect of 96-99% and is eligible for priority review by the FDA

    • Last Update: 2021-04-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pfizer announced today that the U.


    TBE is a viral infection that occurs in the brain and spine and is transmitted to humans through the bite of an infected tick.


    Pfizer’s TBE vaccine is marketed in Europe under the trade names TicoVac and FSME-immune.


    This BLA is based on more than 40 years of experimental evidence outside the United States.


    "Over the years, our TBE vaccine has helped protect millions of people from this potentially serious disease.


    Note: This article is intended to introduce medical and health research, not to recommend treatment options.


    Reference materials:

    [1] US FDA Accepts for Priority Review Pfizer's Application for TicoVac™ (Tick-borne Encephalitis Vaccine).


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.